BR100 Decreased By (-0.46%)
BR30 Decreased By (-0.62%)
KSE100 Decreased By (-0.32%)
KSE30 Decreased By (-0.3%)
AGHA 6.64 Decreased By ▼ -0.03 (-0.45%)
BECO 4.39 Increased By ▲ 0.04 (0.92%)
BML 55.50 Decreased By ▼ -0.67 (-1.19%)
BOP 29.99 Decreased By ▼ -0.13 (-0.43%)
CNERGY 12.80 Decreased By ▼ -0.18 (-1.39%)
CSIL 5.20 Decreased By ▼ -0.11 (-2.07%)
FCCL 51.25 Decreased By ▼ -0.40 (-0.77%)
FFL 14.33 Decreased By ▼ -0.16 (-1.1%)
FNEL 1.21 No Change ▼ 0.00 (0%)
KEL 6.00 Decreased By ▼ -0.06 (-0.99%)
KOSM 5.71 Decreased By ▼ -0.13 (-2.23%)
LOTCHEM 26.25 Increased By ▲ 0.08 (0.31%)
MLCF 89.08 Decreased By ▼ -2.15 (-2.36%)
NBP 162.46 Decreased By ▼ -1.73 (-1.05%)
NCPL 52.51 Decreased By ▼ -0.67 (-1.26%)
NPL 58.50 Decreased By ▼ -0.62 (-1.05%)
OGDC 313.70 Increased By ▲ 0.31 (0.1%)
PACE 9.75 Decreased By ▼ -0.02 (-0.2%)
PAEL 35.00 Decreased By ▼ -0.24 (-0.68%)
PIBTL 14.46 Decreased By ▼ -0.25 (-1.7%)
PPL 219.50 Decreased By ▼ -1.86 (-0.84%)
PRL 91.61 Increased By ▲ 0.39 (0.43%)
PTC 59.24 Increased By ▲ 0.05 (0.08%)
SSGC 23.14 Decreased By ▼ -0.16 (-0.69%)
TBL 8.70 Decreased By ▼ -0.05 (-0.57%)
TELE 7.49 Decreased By ▼ -0.12 (-1.58%)
TPL 21.60 Decreased By ▼ -0.43 (-1.95%)
TPLP 12.25 Decreased By ▼ -0.31 (-2.47%)
TREET 21.71 Decreased By ▼ -0.02 (-0.09%)
TRG 55.45 Decreased By ▼ -0.34 (-0.61%)
By

RIYADH: Saudi King Salman will undergo medical tests on Sunday evening for lung inflammation, the state news agency said, citing a statement from the royal court.

The brief statement did not reveal more details. The 88-year-old king of the world’s biggest oil exporter, a major US ally in the Middle East, also received medical care for lung inflammation in May.

Salman last chaired a cabinet meeting in August, less than two weeks after a royal decree issued by him allowed the cabinet to convene in the absence of the king, crown prince or both.

The decree said that in their absence it would be chaired by the eldest member of the cabinet who is a descendant of Salman’s father King Abdulaziz Al Saud, founder of the Saudi state.

Comments

Comments are closed for this article.